NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
DualityBio Inc.
Tanabe Pharma America, Inc.
Massive Bio, Inc.
SillaJen, Inc.
Travera Inc
Numab Therapeutics AG
Intensity Therapeutics, Inc.
Travera Inc
Simcha IL-18, Inc.
Myeloid Therapeutics
Multitude Therapeutics Inc.
NBE-Therapeutics AG
Kineta Inc.
Shanghai Yunying Medical Technology
Nektar Therapeutics
MultiVir, Inc.
Onkovis GmbH
SPGO Research Mannheim GmbH
Xoft, Inc.
Onkovis GmbH
Hanmi Pharmaceutical Company Limited
Azaya Therapeutics, Inc.
Cytori Therapeutics